MEDICINOVA, INC. Cost of Revenue
MEDICINOVA, INC. (MNOV) reported Cost of Revenue of $1.26 million for the 156-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Expense Statement
us-gaap:CostOfRevenue · last filed 2013-11-07
- MEDICINOVA, INC. cost of revenue for the quarter ending 2013-09-30 was $0.00.
- MEDICINOVA, INC. cost of revenue for the quarter ending 2013-06-30 was $0.00.
- MEDICINOVA, INC. cost of revenue for the quarter ending 2013-03-31 was $0.00.
- MEDICINOVA, INC. cost of revenue for the quarter ending 2012-09-30 was $0.00.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month | Cost of Revenue 129 month | Cost of Revenue 132 month | Cost of Revenue 135 month | Cost of Revenue 138 month | Cost of Revenue 141 month | Cost of Revenue 144 month | Cost of Revenue 147 month | Cost of Revenue 150 month | Cost of Revenue 153 month | Cost of Revenue 156 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 156 month − 10-Q 153 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 derived: sum of 3 quarters · filed 2013-11-07 | $1.26M 10-Q · filed 2013-11-07 | ||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 153 month − 10-Q 150 month · filed 2013-08-08 | $0.00 derived: sum of 2 quarters · filed 2013-08-08 | $1.26M 10-Q · filed 2013-08-08 | |||||||||||
| 2013-03-31 | $0.00 derived: 10-Q 150 month − 10-K 147 month · filed 2013-05-08 | $1.26M 10-Q · filed 2013-05-08 | ||||||||||||
| 2012-12-31 | $1.26M 10-K · filed 2013-03-28 | |||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 144 month − 10-Q 141 month · filed 2012-11-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-08 | $0.00 derived: sum of 3 quarters · filed 2012-11-08 | $0.00 derived: sum of 4 quarters · filed 2012-11-08 | $1.26M 10-Q · filed 2012-11-08 | |||||||||
| 2012-06-30 | $0.00 derived: 10-Q 141 month − 10-Q 138 month · filed 2012-08-09 | $0.00 derived: sum of 2 quarters · filed 2012-08-09 | $0.00 derived: sum of 3 quarters · filed 2012-08-09 | $0.00 derived: sum of 4 quarters · filed 2012-08-09 | $1.26M 10-Q · filed 2012-08-09 | |||||||||
| 2012-03-31 | $0.00 derived: 10-Q 138 month − 10-K 135 month · filed 2012-05-10 | $0.00 derived: sum of 2 quarters · filed 2012-05-10 | $0.00 derived: sum of 3 quarters · filed 2012-05-10 | $0.00 derived: sum of 4 quarters · filed 2012-05-10 | $1.26M 10-Q · filed 2012-05-10 | |||||||||
| 2011-12-31 | $0.00 derived: 10-K 135 month − 10-Q 132 month · filed 2012-03-29 | $0.00 derived: sum of 2 quarters · filed 2012-03-29 | $0.00 derived: sum of 3 quarters · filed 2012-03-29 | $1.26M 10-K · filed 2012-03-29 | ||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 derived: sum of 2 quarters · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | $1.26M 10-Q · filed 2011-11-14 | ||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2011-08-15 | $0.00 10-Q · filed 2011-08-15 | $1.26M 10-Q · filed 2011-08-15 | |||||||||||
| 2010-09-30 | $0.00 10-Q · filed 2011-11-14 | $0.00 derived: sum of 2 quarters · filed 2011-11-14 | $0.00 10-Q · filed 2011-11-14 | |||||||||||
| 2010-06-30 | $0.00 10-Q · filed 2011-08-15 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |